|
Volumn 10, Issue 1, 2010, Pages 90-134
|
Implications of genetic testing for health policy.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
COMMERCIAL PHENOMENA;
CONFIDENTIALITY;
DONOR;
EUROPEAN UNION;
GENETIC ENGINEERING;
GENETIC SCREENING;
GOVERNMENT;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH INSURANCE;
HUMAN;
INFORMED CONSENT;
LABORATORY DIAGNOSIS;
LEGAL ASPECT;
MASS SCREENING;
MENTAL STRESS;
ORGANIZATION AND MANAGEMENT;
PRENATAL CARE;
PRENATAL DIAGNOSIS;
PSYCHOLOGICAL ASPECT;
SOCIAL PSYCHOLOGY;
SPERM;
STANDARD;
UNITED KINGDOM;
UNITED STATES;
WRONGFUL LIFE;
COMMERCE;
CONFIDENTIALITY;
DUTY TO WARN;
EUROPEAN UNION;
FALSE NEGATIVE REACTIONS;
FALSE POSITIVE REACTIONS;
FEDERAL GOVERNMENT;
GENETIC TESTING;
GREAT BRITAIN;
HEALTH CARE COSTS;
HEALTH POLICY;
HUMANS;
INSURANCE, HEALTH;
MASS SCREENING;
PREJUDICE;
PRENATAL CARE;
PRENATAL DIAGNOSIS;
PRIVATE SECTOR;
QUALITY ASSURANCE, HEALTH CARE;
SEMEN;
SEX PRESELECTION;
STATE GOVERNMENT;
STRESS, PSYCHOLOGICAL;
TISSUE DONORS;
UNITED STATES;
WRONGFUL LIFE;
|
EID: 77950363635
PISSN: 15353532
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|